This study provides evidence that the applied manual segmentation protocol for cortical regions first affected by neurofibrillary tau pathology in AD (e.g., the mPRC and ERC) allows different raters to achieve remarkably similar cortical thickness estimates. This evidence concerns the gene MAPT and Alzheimer disease.